Olfactory neuroblastoma, or esthesioneuroblastoma, is a very rare form of cancer arising from a specialized type of nerve cell involved in the sense of smell. It is usually seen developing in the upper end of the nasal cavity in the region around the cribriform plate, which forms the bottom part of the skull. While not frequently observed, it is a form of cancer that is quite locally aggressive and, in some cases, can metastasize to the lymph nodes or to distant organs.
Early detection and management through an interdisciplinary approach of the Head & Neck Oncology team is crucial for optimal results.
The specialists at Tender Palm Hospital, Gomti Nagar, Lucknow, are committed to providing comprehensive care, state-of-the-art imaging, individualized treatment plans, and follow-up for patients with olfactory neuroblastoma.
An olfactory neuroblastoma is a neuroendocrine malignancy arising from the neuroepithelial tissue responsible for olfactory function. This cancer usually affects the roof of the nasal cavity but can also spread to other areas, such as the paranasal sinuses, orbit, or skull base.
This cancer differs from squamous cell carcinoma and adenocarcinoma in that it arises from nerve cells rather than from the lining of the nasal cavity.
Though it progresses slowly, this cancer has the ability to infiltrate adjacent structures and relapse after treatment, which makes an oncology approach necessary.
Yes. Olfactory neuroblastoma is a well-known case of paranasal sinus and nasal cavity cancer. It is an unusual case of malignant tumors of the sinonasal region and needs a special treatment method as compared to other nasal cavity cancers due to its proximity to the skull base and neuroendocrine nature.
The nasal cavity refers to the empty space located inside the nose. It operates as a filter, heating and humidifying the air you breathe in while also providing a surface for olfactory receptors, which give rise to the sense of smell.
Paranasal sinuses refer to spaces filled with air and surrounding the nasal cavity. They include:
Olfactory neuroblastoma commonly arises in the upper part of the nasal cavity but may metastasize to the ethmoid sinuses, orbit, or anterior skull base.
This disease is very rare. It makes up only 3-6% of nasal cavity and paranasal sinuses cancer.
It occurs at all ages but predominantly affects people between 40 and 60 years and, secondarily, young people and adolescents.
Men and women are equally affected by this condition.
The causes are not yet well understood.
Genetic and molecular alterations in olfactory nerve cells are thought to underlie tumor formation. Unlike other sinonasal cancers, this cancer does not appear to be associated with smoking, drinking, or occupational dust exposure.
It usually arises spontaneously in most patients.
Despite no risk factor being proven to cause the condition, olfactory neuroblastoma is more prone to arise in:
Many patients have no risk factors.
The symptoms of this condition are similar to those of chronic sinusitis and nasal polyps.
The symptoms include:
As the tumor enlarges, it could include the bottom of the skull or the eye socket, resulting in neurological or visual signs.
If you have any of the following problems, you should consult an ENT specialist:
Early diagnosis ensures proper management and outcome.
Diagnosis of olfactory neuroblastoma requires clinical, radiographic, and pathological examination.
Your doctor will take your symptoms and history and perform a physical examination.
A flexible or rigid nasal endoscope can be used to visualize the tumor and perform a biopsy.
Imaging studies are vital for evaluating the size and extent of the tumor.
Your doctor will order:
MRI is especially useful in evaluating invasion of the skull base, brain, and orbit.
A biopsy ensures you have an accurate diagnosis.
The tissue sample will be examined through:
Pathologists may also assign the Hyams histological grade, which can predict the tumor's behavior and help plan its treatment.
In accordance with your condition, further investigations can be:
Olfactory neuroblastoma is usually staged according to the Kadish classification, sometimes accompanied by TNM staging.
Staging of olfactory neuroblastoma can be done using:
Accurate staging is important in determining the best course of treatment.
Treatment is determined by:
An integrated Head & Neck Oncology team formulates the best treatment modality.
Surgical treatment of localized tumors is the most prevalent.
Based on the extent of the disease, possible surgeries will include:
Whenever possible, minimally invasive surgical approaches will be used.
Radiation therapy is usually advised postoperatively to reduce the chances of relapse.
However, it may also be used:
Chemotherapy may be suggested:
Even though not part of the standard treatment protocol, targeted therapy and immunotherapy may be considered in some cases, especially if a patient is enrolled in a clinical trial or has undergone certain molecular tests.
Yes. Many patients with localized olfactory neuroblastoma have a good chance of experiencing long-term disease control or cure with the help of surgery and radiation therapy.
The chances of effective treatment depend on:
The prognosis is defined by many factors that include:
Early-stage cancer patients usually have better outcomes than those with advanced cancer.
When left untreated, olfactory neuroblastoma can metastasize to:
The side effects of treatment will depend on the treatment approach used and are managed by the cancer team.
It is highly patient-specific depending on the treatment type.
Patients will need:
Olfactory neuroblastoma is characterized by the risk of late local relapse and distant metastasis many years after the initial treatment.
Follow-up allows:
Follow-up usually involves clinical examination, nasal endoscopy, and imaging procedures.
No. Olfactory neuroblastoma develops from cells located in the olfactory region in the upper nasal cavity. Even though it can spread to the skull base or brain if untreated, it is not a primary brain tumor.
Olfactory neuroblastoma is an older name for esthesioneuroblastoma, which is a more scientific name for this cancer.
Yes. This kind of cancer can metastasize to neighboring structures and regional lymph nodes and even other parts of the body, such as the lungs and bones.
Surgical treatment is used to remove localized tumors, while radiation therapy and chemotherapy might be indicated based on the stage and extent of disease.
Yes. Olfactory neuroblastoma can recur months or years later after treatment.
The Kadish staging system is one of the most commonly used classifications of the extent of olfactory neuroblastoma in the nasal cavity and paranasal sinuses.
Most cases need lifelong follow-up with ENT examination, nasal endoscopy, and imaging studies, as recurrences may happen even after several years of successful treatment.
Tender Palm Super-Speciality Hospital offers advanced Olfactory Neuroblastoma (Esthesioneuroblastoma) treatment in Lucknow, India, at an affordable cost. We have a team of experienced neurosurgeons and head and neck oncology specialists who provide accurate diagnosis and both non-surgical and surgical treatment options including endoscopic skull base resection, radiation therapy, and chemotherapy. Our Neurosurgery and Head and Neck Oncology team has decades of experience in successfully treating Olfactory Neuroblastoma (Esthesioneuroblastoma) in Lucknow, India.
Call us at +91-9076972161
Email at care@tenderpalm.com
Welcome to Tender Palm Hospital. Share your enquiry and connect with our team on WhatsApp.